|
|
|
|||||||
|
|||||||||
(Received for publication, October 7, 1996, and in revised form, November 22, 1996)
From the Division of Endocrinology and the Diabetes Research and
Training Center, Albert Einstein College of Medicine,
Bronx, New York 10461
To delineate the biochemical mechanism by which
increased availability of GlcN impairs insulin action on skeletal
muscle glucose uptake, we replenished the uridine pool during GlcN
administration. Co-infusion of uridine with GlcN prevented the
GlcN-induced fall in skeletal muscle UDP-glucose levels (24.9 ± 5.3 versus 10.1 ± 2.9 nmol/g; p < 0.01) and further increased the skeletal muscle UDP-GlcNAc levels
(198.4 ± 26.3 versus 96.0 ± 8.4 nmol/g;
p < 0.01). Greater reductions in the rates of glucose
infusion (~53%), glucose uptake (~43%), and glycogen synthesis
(~60%) were observed with the addition of uridine. Similarly, the
infusion of uridine alone markedly increased the skeletal muscle levels
of both UDP-glucose (55.2 ± 14.2 versus 17.8 ± 6.1 nmol/g; p < 0.01) and UDP-GlcNAc (86.8 ± 8.8 versus 35.9 ± 8.4 nmol/g; p < 0.05) and induced marked insulin resistance. The decrease in insulin
action on peripheral glucose uptake was highly correlated with the
increase in skeletal muscle UDP-GlcNAc levels. Finally, immunoisolation
of GLUT4-containing vesicles revealed that the rate of labeled GlcN
incorporation was ~100-fold greater following GlcN compared with
saline infusions (p < 0.01). We suggest that the
marked reduction in insulin action induced by GlcN and uridine is
mediated by increased accumulation of muscle
UDP-N-acetylhexosamines, perhaps via altered glycosylation of protein(s) in GLUT4-containing vesicles.
Volume 272, Number 8,
Issue of February 21, 1997
pp. 4889-4895
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. S. Macauley, A. K. Bubb, C. Martinez-Fleites, G. J. Davies, and D. J. Vocadlo Elevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin Resistance J. Biol. Chem., December 12, 2008; 283(50): 34687 - 34695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Copeland, J. W. Bullen, and G. W. Hart Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E17 - E28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Buse Hexosamines, insulin resistance, and the complications of diabetes: current status Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Werstuck, M. I. Khan, G. Femia, A. J. Kim, V. Tedesco, B. Trigatti, and Y. Shi Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model Diabetes, January 1, 2006; 55(1): 93 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Love and J. A. Hanover The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" Sci. Signal., November 29, 2005; 2005(312): re13 - re13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Marshall, O. Nadeau, and K. Yamasaki Glucosamine-induced Activation of Glycogen Biosynthesis in Isolated Adipocytes: EVIDENCE FOR A RAPID ALLOSTERIC CONTROL MECHANISM WITHIN THE HEXOSAMINE BIOSYNTHESIS PATHWAY J. Biol. Chem., March 25, 2005; 280(12): 11018 - 11024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Donthi, G. Ye, C. Wu, D. A. McClain, A. J. Lange, and P. N. Epstein Cardiac Expression of Kinase-deficient 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Inhibits Glycolysis, Promotes Hypertrophy, Impairs Myocyte Function, and Reduces Insulin Sensitivity J. Biol. Chem., November 12, 2004; 279(46): 48085 - 48090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Marshall, O. Nadeau, and K. Yamasaki Dynamic Actions of Glucose and Glucosamine on Hexosamine Biosynthesis in Isolated Adipocytes: DIFFERENTIAL EFFECTS ON GLUCOSAMINE 6-PHOSPHATE, UDP-N-ACETYLGLUCOSAMINE, AND ATP LEVELS J. Biol. Chem., August 20, 2004; 279(34): 35313 - 35319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Obici and L. Rossetti Minireview: Nutrient Sensing and the Regulation of Insulin Action and Energy Balance Endocrinology, December 1, 2003; 144(12): 5172 - 5178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Parker, K. C. Lund, R. P. Taylor, and D. A. McClain Insulin Resistance of Glycogen Synthase Mediated by O-Linked N-Acetylglucosamine J. Biol. Chem., March 14, 2003; 278(12): 10022 - 10027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Weigert, K. Klopfer, C. Kausch, K. Brodbeck, M. Stumvoll, H. U. Haring, and E. D. Schleicher Palmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes: Increased Expression of Glutamine:Fructose-6-Phosphate Aminotransferase Diabetes, March 1, 2003; 52(3): 650 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. E. Walgren, T. S. Vincent, K. L. Schey, and M. G. Buse High glucose and insulin promote O-GlcNAc modification of proteins, including alpha -tubulin Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E424 - E434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-J. J. Pouwels, P. N. Span, C. J. Tack, A. J. Olthaar, C. G. J. Sweep, B. G. van Engelen, J. G. de Jong, J. A. Lutterman, and A. R. Hermus Muscle Uridine Diphosphate-Hexosamines Do Not Decrease Despite Correction of Hyperglycemia-Induced Insulin Resistance in Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5179 - 5184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Goldberg, C. I. Whiteside, and I. G. Fantus The Hexosamine Pathway Regulates the Plasminogen Activator Inhibitor-1 Gene Promoter and Sp1 Transcriptional Activation through Protein Kinase C-beta I and -delta J. Biol. Chem., September 6, 2002; 277(37): 33833 - 33841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. McClain, W. A. Lubas, R. C. Cooksey, M. Hazel, G. J. Parker, D. C. Love, and J. A. Hanover Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia PNAS, August 6, 2002; 99(16): 10695 - 10699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Buse, K. A. Robinson, B. A. Marshall, R. C. Hresko, and M. M. Mueckler Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E241 - E250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. James, D. Tang, A. Ingram, H. Ly, K. Thai, L. Cai, and J. W. Scholey Flux Through the Hexosamine Pathway Is a Determinant of Nuclear Factor {kappa}B- Dependent Promoter Activation Diabetes, April 1, 2002; 51(4): 1146 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, S. Obici, K. Morgan, N. Barzilai, Z. Feng, and L. Rossetti Overfeeding Rapidly Induces Leptin and Insulin Resistance Diabetes, December 1, 2001; 50(12): 2786 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. DeHaven, K. A. Robinson, B. A. Nelson, and M. G. Buse A Novel Variant of Glutamine: Fructose-6-Phosphate Amidotransferase-1 (GFAT1) mRNA Is Selectively Expressed in Striated Muscle Diabetes, November 1, 2001; 50(11): 2419 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. James, A. Ingram, H. Ly, K. Thai, L. Cai, and J. W. Scholey Angiotensin II activates the GFAT promoter in mesangial cells Am J Physiol Renal Physiol, July 1, 2001; 281(1): F151 - F162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, K. Su, M. D. Roos, Q. Chang, A. J. Paterson, and J. E. Kudlow O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability PNAS, May 18, 2001; (2001) 111099998. [Abstract] [Full Text]
|
|
|
|
|
|
M.-J. J. Pouwels, J. R. Jacobs, P. N. Span, J. A. Lutterman, P. Smits, and C. J. Tack Short-Term Glucosamine Infusion Does Not Affect Insulin Sensitivity in Humans J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2099 - 2103. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. N. Span, M.-J. J.M. Pouwels, A. J. Olthaar, R. R. Bosch, A. R.M.M. Hermus, and C.G.J. Sweep Assay for Hexosamine Pathway Intermediates (Uridine Diphosphate-N-Acetyl Amino Sugars) in Small Samples of Human Muscle Tissue Clin. Chem., May 1, 2001; 47(5): 944 - 946. [Full Text] [PDF]
|
|
|
|
|
|
L. D.M.C.-B. Ferreira, L. K. Pulawa, D. R. Jensen, and R. H. Eckel Overexpressing Human Lipoprotein Lipase in Mouse Skeletal Muscle Is Associated With Insulin Resistance Diabetes, May 1, 2001; 50(5): 1064 - 1068. [Abstract] [Full Text]
|
|
|
|
|
|
L. R. James, I. G. Fantus, H. Goldberg, H. Ly, and J. W. Scholey Overexpression of GFAT activates PAI-1 promoter in mesangial cells Am J Physiol Renal Physiol, October 1, 2000; 279(4): F718 - F727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rossetti Perspective: Hexosamines and Nutrient Sensing Endocrinology, June 1, 2000; 141(6): 1922 - 1925. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Gazdag, T. J. Wetter, R. T. Davidson, K. A. Robinson, M. G. Buse, A. J. Yee, L. P. Turcotte, and G. D. Cartee Lower calorie intake enhances muscle insulin action and reduces hexosamine levels Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R504 - R512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Heart, W. S. Choi, and C. K. Sung Glucosamine-induced insulin resistance in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E103 - E112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hawkins, M. Hu, J. Yu, H. Eder, P. Vuguin, L. She, N. Barzilai, M. Leiser, J. M. Backer, and L. Rossetti Discordant Effects of Glucosamine on Insulin-stimulated Glucose Metabolism and Phosphatidylinositol 3-Kinase Activity J. Biol. Chem., October 29, 1999; 274(44): 31312 - 31319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Brady, P. M. Kartha, A. A. Aysola, and A. R. Saltiel The Role of Glucose Metabolites in the Activation and Translocation of Glycogen Synthase by Insulin in 3T3-L1 Adipocytes J. Biol. Chem., September 24, 1999; 274(39): 27497 - 27504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Ciaraldi, L. Carter, S. Nikoulina, S. Mudaliar, D. A. McClain, and R. R. Henry Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects Endocrinology, September 1, 1999; 140(9): 3971 - 3980. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. Robinson, S. M. Willi, S. Bingel, and M. G. Buse Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. Reversal with GH, but not IGF-I, therapy Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E435 - E442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Marshall, P. A. Hansen, N. J. Ensor, M. A. Ogden, and M. Mueckler GLUT-1 or GLUT-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E390 - E400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Hresko, H. Heimberg, M. M.-Y. Chi, and M. Mueckler Glucosamine-induced Insulin Resistance in 3T3-L1 Adipocytes Is Caused by Depletion of Intracellular ATP J. Biol. Chem., August 7, 1998; 273(32): 20658 - 20668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ren, G. A. Gintant, R. E. Miller, and A. J. Davidoff High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2876 - H2883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murata, H. Kaji, K. Iida, Y. Okimura, and K. Chihara Dual Action of Eicosapentaenoic Acid in Hepatoma Cells. UP-REGULATION OF METABOLIC ACTION OF INSULIN AND INHIBITION OF CELL PROLIFERATION J. Biol. Chem., August 10, 2001; 276(33): 31422 - 31428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, K. Su, M. D. Roos, Q. Chang, A. J. Paterson, and J. E. Kudlow O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability PNAS, June 5, 2001; 98(12): 6611 - 6616. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |